# A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy

> **NCT01136655** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 54 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** 80/2.25 μg Symbicort pMDI
- **DRUG:** 80/4.5 μg Symbicort pMDI
- **DRUG:** Foradil Aerolizer 12 μg
- **DRUG:** 40 μg budesonide HFA pMDI
- **DRUG:** placebo HFA pMDI

## Key facts

- **NCT ID:** NCT01136655
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2013-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01136655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01136655, "A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01136655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*